We tested accordance of KRAS mutation status between EBC–DNA samples and resected NSCLC tissue in the subgroup of 19 NSCLC patients (12 with positive and 7 with negative KRAS mutation NSCLC). The gene discussed is KRAS; the disease is non-small cell lung carcinoma.